Exploratory Study of DHA in Systemic Lupus Erythematosus Patients

Clinical trial NCT03396393 · UNKNOWN

Trial details

NCT number: NCT03396393
Sponsor: Kunming Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2018-03-01
Primary completion: 2021-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.